| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | 0.14 | 0.04 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.061 | 0.04 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.04 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.04 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.058 | 0.04 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |